Cornell Chang

460 total citations
9 papers, 369 citations indexed

About

Cornell Chang is a scholar working on Surgery, Pathology and Forensic Medicine and Oncology. According to data from OpenAlex, Cornell Chang has authored 9 papers receiving a total of 369 indexed citations (citations by other indexed papers that have themselves been cited), including 4 papers in Surgery, 4 papers in Pathology and Forensic Medicine and 4 papers in Oncology. Recurrent topics in Cornell Chang's work include Genetic factors in colorectal cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Cornell Chang is often cited by papers focused on Genetic factors in colorectal cancer (4 papers), Cholangiocarcinoma and Gallbladder Cancer Studies (3 papers) and Neuroendocrine Tumor Research Advances (2 papers). Cornell Chang collaborates with scholars based in United States, Germany and Japan. Cornell Chang's co-authors include Frederic M. Waldman, Daniela E. Aust, Robert F. Willenbucher, Dan H. Moore, Linda D. Ferrell, Jonathan P. Terdiman, Gustavo Baretton, Udo Loehrs, Carl Millward and Ronald Balassanian and has published in prestigious journals such as Blood, Cancer and American Journal Of Pathology.

In The Last Decade

Cornell Chang

9 papers receiving 366 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Cornell Chang United States 7 185 172 164 100 92 9 369
Olivia Chan United States 7 216 1.2× 137 0.8× 91 0.6× 127 1.3× 75 0.8× 13 363
Fléjou Jf France 8 202 1.1× 183 1.1× 59 0.4× 130 1.3× 172 1.9× 19 437
Ivo Marchetti Italy 12 57 0.3× 161 0.9× 68 0.4× 115 1.1× 125 1.4× 20 522
Daniela Barana Italy 7 373 2.0× 347 2.0× 73 0.4× 66 0.7× 118 1.3× 12 510
Nicholas Hearle United Kingdom 7 69 0.4× 84 0.5× 59 0.4× 38 0.4× 48 0.5× 8 206
F.M. Nagengast Netherlands 7 381 2.1× 288 1.7× 96 0.6× 54 0.5× 55 0.6× 14 454
Zhenjian Cai United States 9 49 0.3× 92 0.5× 56 0.3× 67 0.7× 133 1.4× 26 302
Adrien Briaux France 11 78 0.4× 111 0.6× 69 0.4× 41 0.4× 146 1.6× 17 304
Lydia Gutiérrez-González Spain 7 84 0.5× 161 0.9× 60 0.4× 168 1.7× 189 2.1× 8 441
Motoko Seto Japan 12 87 0.5× 223 1.3× 70 0.4× 96 1.0× 420 4.6× 17 603

Countries citing papers authored by Cornell Chang

Since Specialization
Citations

This map shows the geographic impact of Cornell Chang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Cornell Chang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Cornell Chang more than expected).

Fields of papers citing papers by Cornell Chang

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Cornell Chang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Cornell Chang. The network helps show where Cornell Chang may publish in the future.

Co-authorship network of co-authors of Cornell Chang

This figure shows the co-authorship network connecting the top 25 collaborators of Cornell Chang. A scholar is included among the top collaborators of Cornell Chang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Cornell Chang. Cornell Chang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

9 of 9 papers shown
1.
2.
Sauter, Craig S., Gautam Borthakur, Luke Mountjoy, et al.. (2023). A Phase 1 Study of NKX101, a Chimeric Antigen Receptor Natural Killer (CAR-NK) Cell Therapy, with Fludarabine and Cytarabine in Patients with Acute Myeloid Leukemia. Blood. 142(Supplement 1). 2097–2097. 17 indexed citations
3.
Aust, Daniela E., Jonathan P. Terdiman, Robert F. Willenbucher, et al.. (2002). The APC/β‐catenin pathway in ulcerative colitis–related colorectal carcinomas. Cancer. 94(5). 1421–1427. 105 indexed citations
4.
Terdiman, Jonathan P., Daniela E. Aust, Cornell Chang, et al.. (2002). High resolution analysis of chromosome 18 alterations in ulcerative colitis-related colorectal cancer. Cancer Genetics and Cytogenetics. 136(2). 129–137. 10 indexed citations
5.
Aust, Daniela E., Jonathan P. Terdiman, Cornell Chang, et al.. (2001). Abstracts 18th European Congress of Pathology Berlin, Germany, September 8–13, 2001. Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin. 439(3). 235–483. 1 indexed citations
6.
Aust, Daniela E., Robert F. Willenbucher, Jonathan P. Terdiman, et al.. (2000). Chromosomal alterations in ulcerative colitis-related and sporadic colorectal cancers by comparative genomic hybridization. Human Pathology. 31(1). 109–114. 53 indexed citations
7.
Balassanian, Ronald, Cornell Chang, Carl Millward, et al.. (2000). Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Human Pathology. 31(11). 1425–1429. 26 indexed citations
8.
Balassanian, Ronald, Cornell Chang, Carl Millward, et al.. (2000). Donor origin of neuroendocrine carcinoma in 2 transplant patients determined by molecular cytogenetics. Human Pathology. 31(11). 1425–1429. 1 indexed citations
9.
Willenbucher, Robert F., Daniela E. Aust, Cornell Chang, et al.. (1999). Genomic Instability Is an Early Event during the Progression Pathway of Ulcerative-Colitis-Related Neoplasia. American Journal Of Pathology. 154(6). 1825–1830. 150 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026